The Market Power in the Chemical Drug Industry of China

FENG HUANG,CHUNJIE WU
DOI: https://doi.org/10.13821/j.cnki.ceq.2013.02.002
2013-01-01
Abstract:In the practices of antitrust and government regulation, one of the key questions is how to define and measure market power. This paper estimates the Lerner Index and its determinants in the chemical drug industry of China. Using the production-approach developed by De Loecker and Warzynski (2012), we estimate the Lerner index as above 0.6 in average, which is statistically significant even after taking into account the kickbacks to medical service suppliers. The index was declining since 2005. Large domestic pharmaceuticals and firms with newly introduced or prescription drug productions are able to charge relatively higher markups. The findings might be useful in deciding how to regulate the industry.
What problem does this paper attempt to address?